So proud to share that today, ICON plc launched Outcome Measures, a collection of end to end capabilities to support sponsors in conducting more patient-centered clinical trials. Key components within this suite of capabilities are: - Atlas, the most comprehensive platform for the selection and deployment of digital measures throughout the trial lifecycle - ePROVIDE, the most extensive collection of COAs from Mapi Research Trust - eCOA + language translation services for COAs If you're conducting a clinical trial, contact us to learn more about this new offering! https://lnkd.in/gtnACxMk #clinicaltrials #patientinnovation
About us
HumanFirst is now an ICON plc company. Our Atlas platform enables the rapid and effective assessment, selection and deployment of evidence-backed digital measures in clinical trials. Together with ICON-sponsored Mapi Research Trust, we enable researchers to select fit-for-purpose tools and assessments to de-risk trial deployment and develop patient-centered clinical strategies that increase the likelihood of regulatory approval.
- Website
-
http://www.iconplc.com/DHT
External link for HumanFirst
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Headquarters
- San Francisco, California
- Type
- Public Company
- Specialties
- digital biomarkers, digital medicine, connected technology, precision medicine, and clinical trials
Locations
-
Primary
San Francisco, California 94104, US
Employees at HumanFirst
Updates
-
Thank you to all who came out for our panel session at #DIA2024 -- It was a great discussion, and we're excited about this next chapter where we'll work closely with Mapi Research Trust to build out an endpoint selection framework that can help researchers with more efficient protocol design. #clinicaltrials #patientoutcomes Roya Sherafat-Kazemzadeh (MD, PhD) Caprice Sassano
-
How did an earlier stage startup like HumanFirst find success, despite being in a highly regulated industry dominated by established, large organizations? A big contributing factor was how our CX team, led by Abby DeVito, built a toolkit of problem solving, relationship building, and storytelling. Read on for how this toolkit influenced HumanFirst's go-to-market approach, product strategy, and ultimately, helped lead us to an acquisition by ICON plc. https://lnkd.in/guhitS_Z #customerexperience #digitalbiomarkers #startups
Series A to Acquisition: Building the Customer Experience function at HumanFirst
medium.com
-
#DIA2024 is around the corner, and we're looking forward to it! If you're attending, stop by our forum on June 19 at 8am PT to learn how a new framework to identify and compare biomarkers across both actively collected & passively-monitored COAs can enable rapid, evidence-based, and fit-for-purpose measures selection for clinical research. Moderated by Caprice Sassano and including speakers Roya Sherafat-Kazemzadeh (MD, PhD) Megan Parisi, MS, CCRP and Thomas Switzer, this forum will build off of our recent paper in Nature Magazine's npj Digital Medicine : https://lnkd.in/eQG9PGWG #DHT #COAs #clinicalresearch
An aligned framework of actively collected and passively monitored clinical outcome assessments (COAs) for measure selection - npj Digital Medicine
nature.com
-
"[I'm] inspired by HumanFirst and all the companies trying to make drug development more efficient, leading to better drugs to market, faster...we have to continue to invest [to] make clinical trials more inclusive and less burdensome on patients and sponsors." Thank you for sharing these important words Chloe Yoo, and thank you to Decent for highlighting Chloe's work at HumanFirst, now part of ICON plc. Read the full interview at the link in comments 👇
"Mission driven work – knowing that what you do day in and day out helps people and could help you or your family down the line is really rewarding." 🦄 This week for Decent’s Healthcare Rebel Alliance series I interviewed Chloe Yoo, CFO of HumanFirst, where she worked with my friend Andrea Coravos to enable precision measures in clinical research and make better drugs faster, and recently ran HumanFirst's sale to ICON plc. Chloe is a sharp "relentless doer" who has built a great reputation through her non-linear career in our industry by diving in and learning on the fly. Mission-minded finance people are a force multiplier for good work. Read her full interview on our blog, link in comments.
-
As the use of wearable sensors increases across age and income brackets, pharmaceutical sponsors are increasingly leveraging digital biomarkers and digital endpoints in trial protocols. HumanFirst's Head of Go to Market Abby DeVito shares learnings and insights on the evolving landscape of digital biomarkers from the recent Regeneron Digital Biomarker Summit. Read more of her takeaways: https://lnkd.in/gAtTdiE5 #clinicaltrials #digitalhealth #patientoutcomes
7 Key Insights: Driving toward better patient outcomes in drug development
gohumanfirst.com
-
HumanFirst reposted this
We are very proud to share that HumanFirst has won the MedTech Breakthrough award. Congratulations to the whole team! We are thrilled to work in close collaboration with you to improve the lives of humans by accelerating the use of measures that matter in clinical trials.
Success for HumanFirst, an ICON plc company, at the 2024 MedTech Breakthrough Awards. It has been named Best Clinical Trial Technology Solution Provider for its solutions that help sponsors accelerate and improve digital health technology selection to optimise protocol design. The award recognises the work we are doing to deploy better and more effective precision measurements into more clinical trials. Learn more at https://ow.ly/cruk50RJwHh #precisionmeasures #DHTs
-
Thrilled to be named the Best Clinical Trial Technology Solution Provider by MedTech Breakthrough! We are so excited to continue helping researchers build effective trials with patient-centric measures and innovative health technologies.
Success for HumanFirst, an ICON plc company, at the 2024 MedTech Breakthrough Awards. It has been named Best Clinical Trial Technology Solution Provider for its solutions that help sponsors accelerate and improve digital health technology selection to optimise protocol design. The award recognises the work we are doing to deploy better and more effective precision measurements into more clinical trials. Learn more at https://ow.ly/cruk50RJwHh #precisionmeasures #DHTs
-
Today is the day! Stop by to hear Andrea Coravos and Ida Sim talk about the future of wearables in medicine at the #STATBreakthrough Summit.
Meet Andy Coravos on May 16 during her session at the #STAT Breakthrough Summit West to understand what role industry and academia should play in changing how our devices monitor us. https://ow.ly/cCx850RoKv9
-
HumanFirst reposted this
We're hiring at ICON/MAPI Research Trust! If you are passionate about COAs and digital health technologies, this role is for you. Come join us to shape the future of patient focused protocol design in clinical trials. https://lnkd.in/eGzMdTdX